Table 2.
Baseline biochemical disease activity and glucose metabolism
Author and reference | GH (ng/mL) |
IGF-1 (ULN) |
Glucose (mg/dL) | T2DM (%) | A1c (%) |
---|---|---|---|---|---|
Corica G. et al. [21] | 3.4 | 1.3 | 93.0 | 14.0 | 5.7 |
Urbani C. et al. [14] | 4.3 | 1.9 | 104.0 | 38.0 | 5.8 |
Chiloiro S. et al. [24] | 4.0 | 3.1 | 109.0 | 14.7 | 5.9 |
Araujo-Castro M. et al. [15] | NA | 3.3 | 110.5 | 29.2 | 6.4 |
Ruiz S. et al. [13] | 19.0 | 1.8 | NA | 14.0 | NA |
Stelmachowska-Banaś M. et al. [33] | 3.9 | 2.3 | 111.0 | 15.4 | 5.9 |
Witek P. et al. [34] | 3.1 | 1.9 | NA | 10.3 | 5.6 |
Shimon I. et al. [37] | 1.9 | 1.8 | 109.0 | 31.4 | 6.1 |
Gadelha M. et al. [12] | 4.0 | 2.4 | NA | 22.0 | 5.9 |
Lasolle H. et al. [40] | NA | 1.7 | 101.0 | NA | 5.8 |
Wolf P. et al. [41] | 7.8 | 1.6 | NA | 39.0 | 5.8 |
Abbreviatures: BMI: body mass index, GH: growth hormone, IGF-1: Insulin-like Growth Factor 1, ULN: upper limit of normal, T2DM, Type 2 diabetes mellitus